Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Catalent Pharma Solutions has announced investments at its Schorndorf, Germany facility for the expansion of its drug development and delivery capabilities.
Subscribe to our email newsletter
The company adds R&D and commercial scale fluid bed technology, OptiMelt hot melt extrusion, at its German facility and elevates cGMP compliance for handling of OEB class 3 customer products.
Catalent Modified Release Technologies president Ian Muir said the expansion follows investments in OSDrC OPTIDOSE optimized controlled release dose delivery technology at Kentucky site and Lyopan fast-dissolve lyophilized tablet technology.